
Bcl-rambo Antibody (6D161) is a mouse monoclonal IgG1 antibody that detects Bcl-rambo in human samples through applications such as western blotting (WB), immunoprecipitation (IP), and immunofluorescence (IF). Bcl-rambo plays a crucial role in the regulation of apoptosis, a programmed cell death process essential for maintaining cellular homeostasis and eliminating damaged cells. Anti-Bcl-rambo antibody (6D161) targets this protein primarily in the mitochondria, where Bcl-rambo exerts pro-apoptotic effects. The mitochondrial localization is significant because Bcl-rambo interacts directly with key components of the apoptotic machinery, facilitating the release of cytochrome c from the mitochondria into the cytosol, which is a critical step in the activation of caspases and the execution of apoptosis. Bcl-rambo′s unique C-terminal region, which contains two tandem repeats preceding the membrane anchor, distinguishes Bcl-rambo from other Bcl-2 family members and is essential for function. By understanding the localization and function of Bcl-rambo, researchers can gain insights into the mechanisms of apoptosis and implications in various diseases, including cancer, where dysregulation of apoptotic pathways is often observed. Bcl-rambo monoclonal antibody (6D161) serves as an invaluable tool for studying these processes in human tissues.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Bcl-rambo Antibody (6D161) | sc-70416 | 50 µg/0.5 ml | $322.00 |